Beijing Beilu Pharmaceutical Co., Ltd (300016.SZ)
CNY 6.99
(-1.55%)
CNY 6.99
(-1.55%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.03 Billion CNY | 15.78% |
| 2022 | 892.27 Million CNY | 9.05% |
| 2021 | 818.22 Million CNY | -14.37% |
| 2020 | 955.5 Million CNY | 451.32% |
| 2019 | 173.31 Million CNY | 108.99% |
| 2018 | 82.92 Million CNY | 15.74% |
| 2017 | 71.64 Million CNY | 31.71% |
| 2016 | 54.39 Million CNY | -53.66% |
| 2015 | 117.38 Million CNY | -51.22% |
| 2014 | 240.67 Million CNY | 293.5% |
| 2013 | 61.16 Million CNY | 2.56% |
| 2012 | 59.63 Million CNY | 79.71% |
| 2011 | 33.18 Million CNY | 343.2% |
| 2010 | 7.48 Million CNY | -57.46% |
| 2009 | 17.6 Million CNY | -33.62% |
| 2008 | 26.51 Million CNY | -48.36% |
| 2007 | 51.35 Million CNY | -5.07% |
| 2006 | 54.09 Million CNY | 26.55% |
| 2005 | 42.74 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 1.16 Billion CNY | -4.14% |
| 2024 Q1 | 1.07 Billion CNY | 3.62% |
| 2024 Q2 | 1.21 Billion CNY | 13.3% |
| 2023 Q2 | 939.38 Million CNY | -0.46% |
| 2023 Q1 | 943.74 Million CNY | 5.77% |
| 2023 FY | 1.03 Billion CNY | 15.78% |
| 2023 Q4 | 1.03 Billion CNY | 4.82% |
| 2023 Q3 | 985.57 Million CNY | 4.92% |
| 2022 Q2 | 876.99 Million CNY | 3.45% |
| 2022 FY | 892.27 Million CNY | 9.05% |
| 2022 Q4 | 892.27 Million CNY | 5.58% |
| 2022 Q3 | 845.1 Million CNY | -3.64% |
| 2022 Q1 | 847.71 Million CNY | 3.6% |
| 2021 FY | 818.22 Million CNY | -14.37% |
| 2021 Q1 | 931.35 Million CNY | -2.53% |
| 2021 Q4 | 818.22 Million CNY | -10.7% |
| 2021 Q3 | 916.28 Million CNY | -1.89% |
| 2021 Q2 | 933.95 Million CNY | 0.28% |
| 2020 Q3 | 459.89 Million CNY | 22.65% |
| 2020 Q2 | 374.95 Million CNY | 36.72% |
| 2020 Q4 | 955.5 Million CNY | 107.77% |
| 2020 FY | 955.5 Million CNY | 451.32% |
| 2020 Q1 | 274.23 Million CNY | 58.23% |
| 2019 Q1 | 82.1 Million CNY | -0.99% |
| 2019 FY | 173.31 Million CNY | 108.99% |
| 2019 Q4 | 173.31 Million CNY | 48.72% |
| 2019 Q3 | 116.53 Million CNY | -0.09% |
| 2019 Q2 | 116.64 Million CNY | 42.06% |
| 2018 Q3 | 78.07 Million CNY | 7.99% |
| 2018 FY | 82.92 Million CNY | 15.74% |
| 2018 Q1 | 71.89 Million CNY | 0.34% |
| 2018 Q2 | 72.29 Million CNY | 0.56% |
| 2018 Q4 | 82.92 Million CNY | 6.21% |
| 2017 Q4 | 71.64 Million CNY | -9.42% |
| 2017 Q3 | 79.1 Million CNY | -11.28% |
| 2017 Q2 | 89.15 Million CNY | 3.71% |
| 2017 Q1 | 85.96 Million CNY | 58.04% |
| 2017 FY | 71.64 Million CNY | 31.71% |
| 2016 Q1 | 134.52 Million CNY | 14.6% |
| 2016 Q4 | 54.39 Million CNY | -12.91% |
| 2016 Q3 | 62.46 Million CNY | -24.62% |
| 2016 Q2 | 82.86 Million CNY | -38.4% |
| 2016 FY | 54.39 Million CNY | -53.66% |
| 2015 Q1 | 242.44 Million CNY | 0.74% |
| 2015 FY | 117.38 Million CNY | -51.22% |
| 2015 Q2 | 235.33 Million CNY | -2.93% |
| 2015 Q4 | 117.38 Million CNY | -52.85% |
| 2015 Q3 | 248.95 Million CNY | 5.79% |
| 2014 Q1 | 55.73 Million CNY | -8.88% |
| 2014 Q3 | 56.67 Million CNY | 3.46% |
| 2014 FY | 240.67 Million CNY | 293.5% |
| 2014 Q4 | 240.67 Million CNY | 324.64% |
| 2014 Q2 | 54.78 Million CNY | -1.7% |
| 2013 FY | 61.16 Million CNY | 2.56% |
| 2013 Q1 | 56.96 Million CNY | -4.48% |
| 2013 Q2 | 55.17 Million CNY | -3.14% |
| 2013 Q3 | 59.52 Million CNY | 7.88% |
| 2013 Q4 | 61.16 Million CNY | 2.75% |
| 2012 Q4 | 59.63 Million CNY | 81.9% |
| 2012 Q3 | 32.78 Million CNY | 6.59% |
| 2012 Q2 | 30.75 Million CNY | 2.97% |
| 2012 Q1 | 29.86 Million CNY | -9.99% |
| 2012 FY | 59.63 Million CNY | 79.71% |
| 2011 FY | 33.18 Million CNY | 343.2% |
| 2011 Q1 | 10.59 Million CNY | 41.51% |
| 2011 Q4 | 33.18 Million CNY | 134.23% |
| 2011 Q3 | 14.16 Million CNY | -4.96% |
| 2011 Q2 | 14.9 Million CNY | 40.68% |
| 2010 Q2 | 24.75 Million CNY | -11.14% |
| 2010 Q3 | 9.12 Million CNY | -63.16% |
| 2010 Q4 | 7.48 Million CNY | -17.91% |
| 2010 FY | 7.48 Million CNY | -57.46% |
| 2010 Q1 | 27.86 Million CNY | 58.28% |
| 2009 Q3 | 29.96 Million CNY | 23.77% |
| 2009 Q2 | 24.21 Million CNY | 0.0% |
| 2009 FY | 17.6 Million CNY | -33.62% |
| 2009 Q4 | 17.6 Million CNY | -41.25% |
| 2008 FY | 26.51 Million CNY | -48.36% |
| 2008 Q4 | 26.51 Million CNY | 0.0% |
| 2008 Q2 | 50.81 Million CNY | 0.0% |
| 2007 FY | 51.35 Million CNY | -5.07% |
| 2007 Q4 | 51.35 Million CNY | 0.0% |
| 2006 FY | 54.09 Million CNY | 26.55% |
| 2005 FY | 42.74 Million CNY | 0.0% |